We have isolated drug-resistant variants from adenovirus-transformed rat cells that had concomitantly lost their transformed phenotype. Our aim was to determine the reason for reversion, to attempt retransformation with 5-azacytidine (5-AzaC) and to study the mechanism of retransformation. Of the three cell lines studied, one (G4F) had lost the integrated Ela genes, whereas the other two (G2a and G5) failed to synthesize Ela RNA or proteins. Incubation of these cell lines with 3 ~tM-5-AzaC for 2 days, followed by passaging in the absence of drug, gave rise to transformed foci in all of the cell lines. The efficiency of transformation was typical of each cell line. Surprisingly, retransformation was not accompanied by the reappearance of detectable levels of E 1 a gene activity in the G2aAza and G5Aza cell lines. In search of a mechanistic explanation for the loss of gene activity in the revertants and its reappearance in the retransformants, we examined the state of methylation of the E I a gene region in these cells. Neither the Ela promoter nor its upstream region was methylated in the revertants or the 5-AzaC retransformants. These results suggest that E 1 a transcription was suppressed by mechanisms other than DNA methylation and that 5-AzaC could retransform these cells without lifting the Ela-suppressed state.
Introduction
There is considerable evidence that DNA methylation represents an epigenetic mechanism for controlling gene expression. Transcriptionally active genes or their flanking sequences frequently show evidence of hypomethylation when compared to their inactive form. Furthermore, alterations in the profile of DNA methylation are often heritable in somatic cells, thus providing a mechanism for epigenetic alterations in gene expression (Bird, 1986; Wigler et al., 1981) . There is evidence to suggest that abnormalities in DNA methylation may be specifically related to carcinogenesis (Jones, 1985; Riggs & Jones, 1983) . A decreased level of DNA methylation has been found in a number of tumours and tumour cell lines (Gama-Sosa et al., 1983; Kuhlmann & Doerfler, 1983; Lapeyre et aI., 1981 ; Nyce et al., 1983) . The ras and myc oncogenes were found to be hypomethylated in tumours compared to the corresponding normal tissues (Cheah et al., 1984; Feinberg & Vogelstein, 1983) .
A well known inhibitor of DNA methylation, 5-azacytidine (5-AzaC), is a useful tool for assessing the role of this type of epigenetic phenomenon in cancer, because several studies have shown that the agent is not demonstrably mutagenic in eukaryotic cells (Delers et al., 1984; Kerbel et al., 1984; Landolph & Jones, 1982) . The drug is capable of direct transformation of cultured cells (Benedict et al., 1977; Harrison et al., 1983; Hsiao et al., 1985) , but the mechanism of action is not clearly defined. Samid et al. (1987) have successfully retransformed revertants by treatment with 5-AzaC. We have isolated drug-resistant variants from adenovirus-transformed rat cells that had concomitantly lost the transformed phenotype Sircar & Weber, 1988) . Our aim was to determine the reason for reversion and to establish whether these cells could be retransformed with 5-AzaC. It was hoped that a study of these mechanisms might shed light on the molecular basis for reversion and retransformation of mammalian cells.
Methods
Cells. F4 rat cells were obtained from Bruce Stillman (Cold Spring Harbor Laboratory). They were derived from embryonic rat brain cells transformed by adenovirus 2 (Gallimore et al., 1977) . F4 cells were recloned three times in succession and variants resistant to methylglyoxal bis(guanylhydrazone) (MGBG) were isolated from these subclones . These isolates were named G2, G4 and G5 and have been described before Sircar & Weber, 1988) . Variant subclones derived from G2 and G4 were named G2a and G4F, respectively, and both of these cell lines maintained MGBG resistance and a detransformed phenotype. G2a and G5 contained integrated E1 genes indistinguishable from those of the parental F4 cells. However, the G4F line had undergone a major deletion event, which removed any detectable traces of Ela genes, leaving about one 0000-9311 © 1990 SGM copy of the late region intact. G4F could therefore serve as an excellent transformation-negative control cell line. The transformation-positive control cell lines were the parental F4 cells and G4NF, a transformed derivative of G4. The FR3T3 cell is a normal rat fibroblast cell line (Seif & Cuzin, 1977) . All cell culture was in Petri dishes in Dulbecco's minimal essential medium and 5% foetal calf serum in air-CO2 incubators at 37 °C. Growth in soft agar (0.33 ~ Noble agar, Difco) was performed as described previously .
Azacytidine treatment. The ceils were treated with freshly prepared 3.0 p.M-5-AzaC (Sigma) or 3.0 gM-6-azacytidine (6-AzaC; ICN Biochemicals) at 48 h after plating. Cells were subcultured thereafter in the absence of the nucleosides and observed for phenotypic alterations. Oncogenic transformation was determined by focus formation, growth in soft agar or tumorigenicity in nude mice.
For in vivo treatment 6-to 8-week-old nude mice were inoculated subcutaneously with 5 x 105 cells/site. Twenty-four h later 400 Ixg of freshly prepared 5-AzaC in 200 p.1 of phosphate-buffered saline was administered intraperitoneally into each treated animal (20 mg/kg).
Analysis of DNA, RNA and protein. Total intracellular DNA was extracted from NP40-isolated nuclei by the SDS~roteinase K-phenol method and Southern blot analysis, performed according to standard procedures (Maniatis et al., 1982) . Cytoplasmic RNA was purified according to Maniatis et al. (1982) and separated on a 1% agarose gel containing 0.66 M-formaldehyde and blotted onto Hybond nylon membranes. Western blots of total cell lysates were from SDSmercaptoethanol denaturing gels, as described before (Sircar & Weber, 1988) .
Results

Reversion due to loss o f E l a gene expression
The G2a, G 4 F and G5 cell lines had been in culture continuously for over 6 m o n t h s prior to t r e a t m e n t with 5-AzaC and had r e m a i n e d stable, fiat revertants during this time. Southern blot analysis showed no changes in integrated adenovirus sequences, except in the case of G 4 F , which had lost all traces of E 1 a genes at the time of isolation (unpublished results). To determine whether loss of E 1 a gene expression caused the detransformation we verified the synthesis of E l a proteins a n d R N A . Western blotting showed that none of these three cell lines contained detectable levels of E l a proteins (Fig. 1 , lanes 4, 6 and 8). N o r t h e r n blotting of cytoplasmic R N A confirmed this absence of E 1 a gene expression (compare Fig. 2 lanes 1 and 2 with lanes 3, 4 and 6). It is therefore presumed that the loss of E l a gene expression was responsible for the revertant phenotype in the case of the G 2 a and G5 cells. This transcriptional silencing had occurred at the time of the initial isolation of the G5 cells subsequent to mutagenesis Sircar & Weber, 1988) . In the case of the G2a cell line this had h a p p e n e d more recently and occurred spontaneously during subcloning of the E 1 a-positive detransformed cell line. The expression of E l b genes was also verified by Western blotting. E 1 b transcription is absolutely dependent on the presence of E l a proteins (Flint, 1981) , so it Fig. 2. Northern blot analysis of Ela-specific RNA in transformed (F4), revertant (G2a, G5) and 5-AzaC retransformed cells. The nicktranslated probes were the 2.1 kb BamHI fragment of human fl-actin to quantify the RNA, and the cDNA of the 13S product of adenovirus type 2 Ela. Samples consisted of 40 ~tg of cytoplasmic RNA from the cells indicated. The filter was first hybridized with fl-actin, then washed and hybridized with the Ela probe. F4 (lanes 1 and 2) and G5 (lanes 3 and 4) were run in duplicate. The panel on the right (8 and 9) is a 16-fold less exposed version of the two F4 tracks (1 and 2). Note that the increased Ela RNA signal in lane 7 is merely due to a greater amount of total RNA loaded, as shown by the fl-actin probe. Numbers on the right-hand side indicate size in kbp.
was not surprising that no E l b proteins were detected in cells other t h a n F4 (results not shown).
Retransformation o f revertants with 5-AzaC
The simplest explanation for the loss of E l a gene expression in the transformation revertants G2a and G5 cells is transcriptional silencing by methylation. To test this hypothesis monolayers of cells were exposed to 3 ~tM-5-AzaC for 48 h and then serially passaged in its absence. This t r e a t m e n t did not cause observable cytopathic effects. After the fifth passage transformed foci composed of strikingly rounded cells began to be observable in the G2a monolayer of cells (Fig. 3b) . The number of foci progressively increased in the course of subsequent passages, such that by about 30 passages the cell population appeared to be composed entirely of transformed cells (Fig. 3c) . Morphological transformation was slower in the other cell lines tested; G5 and FR3T3 developed foci after 16 passages and G4F only after 27 passages. However, these cells did not develop the rounded morphology seen in G2a cells. That morphological transformation was induced by 5-AzaC and not merely by serial passaging was shown by the fact that these cells have been passaged continuously for 1 (G4F, G2a) to 3 years (G5, FR3T3) without such changes. Furthermore, a similar experiment using 6-AzaC treatment of G2a cells did not result in transformation, even after 16 passages (Table 1) .
Sixteen passages after treatment with 5-AzaC all the cell lines were tested for growth in soft agar and for tumour formation in nude mice. The efficiency of colony formation and the morphology of the colonies in agar was quite different for the different cell lines tested. A representative sample of colonies is illustrated in Fig. 4 . The G2a cells formed the largest and most striking colonies, with rough boundaries showing cells migrating outward (Fig. 4d) . This property was even more pronounced when cells from explanted nude mouse tumours induced by G2a/5-AzaC were tested in soft agar (Fig. 4a) . The colony formation efficiency of these tumour cells also increased from 12~ (G2a/5-AzaC) to 86~ (G2at/5-AzaC), a clear case of tumour progression. Because colony size appeared to be an important difference in this e x p e r i m e n t we d e t e r m i n e d the relative proportion of small, medium, large and giant colonies in agarose for each cell line (Table 1) . These d a t a show that the efficiency of 5-AzaC retransformation is variable and highly d e p e n d e n t on the nature of the starting cell line. This conclusion was corroborated by the differential tumorigenicity of the cell lines in nude mice (Table 2) . Tumours developed with all cell lines tested, including the E l a gene-negative G 4 F line and the n o r m a l rat fibroblast line FR3T3. The analogue 6-AzaC, which does not inhibit methylation (Jones, 1986) , did not induce tumours with G 2 a cells, the cell line most responsive to 5-AzaC.
To determine whether 5-AzaC would also retransform G 2 a cells in vivo, nude mice were inoculated subcutaneously with the M G B G -r e s i s t a n t G 2 a cells, and intraperitoneally the next day with 5-AzaC. Tumours developed at the sites of cell inoculation after a s o m e w h a t longer interval than in the case of in vitro treated cells (Table 2) . Cells explanted from a tumour were resistant to M G B G , confirming that the tumours originated from G 2 a cells. G2a/5-AzaC 14-28 14/18 1.5-2.5 G4F/5-AzaC 24-30 2/9 0-2-0.5 G5F/5-AzaC 3(~50 4/9 1-0-1-5 FR3T3/5-AzaC 40 7/9 0.7-1.0 G2a/6-AzaC 43 0/9 -5-AzaC treatment in vitro t G2a 43 6/9 1-5-2.0 * Five x 105 cells/site were injected subcutaneously (at three sites) in nude mice 16 passages after treatment with 5-AzaC. Tumour size was recorded at day 60. Cells were considered non-tumorigenic when no evidence of tumour formation was seen 2 months after injection.
"[" Twenty-four h after inoculation of nude mice with untreated cells the animals were injected with 5-AzaC (20 mg/kg) intraperitoneally.
5-Azacytidine and transformation 589
Mechanism of retransformation
Retransformation of the revertants after 5-AzaC treatment could have occurred via several possible mechanisms. One such mechanism in the case of G2a and G5 cells could have been the reactivation of E 1 a expression, which was tested by checking for the synthesis of E l a proteins and m R N A at approximately the same passage number as in the transformation tests. As shown by the Western blot (Fig. 1 ) and the Northern blot (Fig. 2) there appeared to be no significant expression of the E 1 a genes before or after 5-AzaC treatment. The slight R N A signal observed in G5/5-AzaC (Fig. 2 , lane 5) measured 6% of that expressed by the transformed F4 cells and was not sufficient to induce a detectable level of E l a proteins (Fig. 1, lane 7) . It was conceivable that the apparent lack of E l a expression was merely a reflection of the heterogeneous nature of the mixed cell populations. This possibility was unlikely because the G2at/5-AzaC cells, which were derived from a nude mouse tumour induced by G2a cells, did not express detectable levels of E l a proteins.
The reason for the lack of reactivation of E l a gene expression was also investigated by determining the state of methylation of these genes before and after 5-AzaC treatment.
Cellular D N A was digested with XbaI followed by //pail, and Southern blots were probed with the BgllI E fragment of adenovirus-2, representing the E1 region (Fig. 5) . This procedure would be expected to reveal the state of numerous CG sequences flanking and within the Etp, region. Surprisingly, there was no evidence of methylation in this region in any of the cells tested (Fig. 5b) . In a second experiment the analysis was restricted to a smaller region of E l a encompassing the promoter and part of the E l a coding region (see Fig. 5 map for details). Again no difference was found between the transformed F4 cells and the G2a or G2a/5-AzaC ceils (Fig. 5c ). The same conclusion was drawn from a similar experiment using an AvaI-AccI (nucleotides 192 to 757) fragment, which encompassed both E l a enhancers and also included G5 and G5/5-AzaC cells (data not shown).
These results indicated that reversion and 5-AzaCmediated retransformation were due to changes in genes other than Ela. This conclusion is consistent with the observed 5-AzaC-mediated transformation of the G4F and FR3T3 cells, which do not possess E l a genes.
Discussion
One of the objectives of cancer research is to identify means of arresting or reversing the transformed pheno- Virus map (1 to 3) F4, G2a and G2a/5-AzaC, respectively, digested with XbaI; (4 to 6) same samptes.~lsodigested with HpalI; (7, 9 and 11) F4, G5 and G5/5-AzaC, respectively, digested with Accl; (8, 10 and 12) F4, G5 and G5/5-AzaC, respectively, also digested with HpalI.
type. It is therefore interesting that stable reversion can be obtained by selection for resistance to a cancer chemotherapeutic agent such as M G B G (Sircar et al., , 1988 . In this report we have shown that these revertants, which no longer express the oncogene Ela, were retransformable by 5-AzaC without reactivation of Ela. In fact two cell lines which do not carry E l a genes were also transformed by 5-AzaC.
In two of the revertants, G2a and G5, reversion to the non-transformed phenotype occurred as a result of transcriptional arrest of the Ela genes. It should be recalled that these cells contain 16 tandemly integrated copies of the left 62% joined to the right 4% of the adenovirus chromosome (Flint, 1981; Fig. 5 ). Surprisingly this loss of Ela expression of most or all 16 copies was not accompanied by any detectable increase in methylation of this region.
The treatment of these revertants with 5-AzaC could not, and in fact did not result in increased cleavage with HpalI. What might then have been the cause of retransformation? The broad hypomethylating effects of 5-AzaC could have activated cellular oncogenes or cellular effector genes. Although 5-AzaC is not demonstrably mutagenic in mammalian cells, the drug has been shown to have variable effects on tumour progression Jones, 1986; Kerbel et al., 1984; Olsson et al., 1985; Olsson & Forchhammer, 1984) . It may activate genes necessary for progression in some cases, or serve to activate genes that repress progression in others (Babiss et al., 1985) . Our results support previous reports that 5-AzaC is capable of the direct transformation of cultured cells (Benedict et al., 1977; Harrison et al., 1983; Hsiao et al., 1985) , as well as being tumorigenic in animals (Carr et al., 1984; Samid et al., 1987) . These studies not only cast a grave doubt on the use of demethylating drugs in cancer therapy, but also point to the need for more investigation of cotransforming factors or transformation effector genes, which would also be operative in tumour progression.
